Arctic Pharma is a biotechnology company that specializes in the development of innovative treatments for glycolytic cancers. The company is actively engaged in research and development in oncology, with the aim of finding effective therapeutic solutions for patients with these specific types of cancer.
The company has a dedicated research board that helps lead and monitor the research projects. Arctic Pharma is also obliged to report improper use of information, which underlines the company's focus on ethical practice and transparency. For more detailed and updated information about the company's activities and projects, information is available on their website.
